Richard P. Batycky
Chief Technology Officer and Site Head
Acorda Therapeutics Inc.
United States of America
Dr. Richard P. Batycky, also known as Rick, Ph.D. has been the Chief Technology Officer and Site Head of Acorda Therapeutics, Inc. since October 2014. Dr. Batycky Co-Founded Civitas Therapeutics, Inc. in 2009 and served as its Chief Scientific Officer since December 2010. He has more than a decade of experience in drug development with a particular focus on inhaled therapies. Dr. Batycky served as Chief Scientific Officer and Senior Vice President of Research & Development at Pulmatrix, Inc. Prior to joining Pulmatrix, Dr. Batycky was Vice President of Research and Development for Alkermes, Inc. While at Alkermes, Dr. Batycky oversaw many aspects of product development including the inhaled therapeutic platform, which is now the ARCUS™ platform at Civitas. He was involved in the development of over 10 product candidates (both proprietary and partnered) across multiple delivery platforms (pulmonary, injectable and oral) in various stages. Prior to joining Alkermes, Dr. Batycky was an original employee of Advanced Inhalation Research (AIR®) until it was acquired by Alkermes. Prior to AIR®, Dr. Batycky was an Assistant Professor of Chemical Engineering at the University of Alberta and a post-doctoral fellow at Pennsylvania State University. Dr. Batycky received his PhD from MIT in Chemical Engineering.
Bipolar Disorder Stroke Research & Therapy